Table 1.
Aspects to be considered when documenting a case of a herb–drug interaction
| Aspect | Specification |
|---|---|
| Characteristics of user | Age/gender/ethnicity |
| (Co-)morbidity/anamnesis | |
| Characteristics of herbal product/conventional drug | Composition/dosage form |
| Phytochemical constituents/quality of herbal product | |
| Use of herbal product/conventional drug | Reason for/duration of use |
| Route of administration/dose/time and dose/day | |
| Use of other products | Conventional/unconventional products |
| Characteristics of adverse event | Clinical signs/symptoms |
| Laboratory findings | |
| Conventional drug levels | |
| Evaluation of adverse event | Temporal time sequence |
| Dechallenge/rechallenge | |
| Formal causality assessment | |
| Stability of patient before/after adverse event | |
| Coverage of existing literature | |
| Product-bound/user-bound/circumstances-bound risk modifiers (e.g. frailness/infrequent genotype) | |
| Evaluation of confounding factors | Change in (co-)morbidity |
| Change in intake food/alcohol/recreational drugs | |
| Change in conventional/unconventional products | |
| Change in patient adherence |